|Bid||455.00 x 0|
|Ask||470.00 x 0|
|Day's range||455.00 - 470.00|
|52-week range||280.00 - 1,235.00|
|Beta (5Y monthly)||1.26|
|PE ratio (TTM)||N/A|
|Earnings date||10 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||9.86|
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
MaxCyte, Inc. ( LON:MXCT ) shareholders might be concerned after seeing the share price drop 28% in the last quarter...
My name is Sean Menarguez, and I'm the director of investor relations here at MaxCyte. On the call from MaxCyte, we have Doug Doerfler, president and chief executive officer; and Ron Holtz, interim chief financial officer.